Golden Helix Symposia: Next Generation Pharmacogenomics
The 2015 Golden Helix Symposium "Next Generation Pharmacogenomics" will be held in Kuala Lumpur, Malaysia, March 11-13, 2015. Pharmacogenomics seeks to apply technologies, methods and discoveries from the field of genomics to improve the efficacy and safety of therapeutics. Pharmacogenomics has the potential to lead to personalized medicine, which is the use of information and data from the patient’s genotype, or level of gene expression to select a medication, provide a therapy, or initiate a preventative measure that is particularly suited to that patient at the time of administration. This concept has been highlighted as “therapy with the right drug at the right dose in the right patient”.
South East Asia (SEA) is a melting pot of many ethnic groups in which the study of Pharmacogenomics in this region would be interesting as it is necessary in order that the benefit of this knowledge would impact on patient care now and in the future. This will probably be one of the biggest conference/symposium on pharmacogenomics in this region. It will bring together researchers in the field of pharmacogenomics, and those involved will not only be updated on new knowledge in this field, but will also facilitate collaborations, and also spur others to carry out more research in this important field.
The Symposium Faculty consists of internationally renowned speakers mostly from Southeast Asian countries but also from Europe and the US. The meeting will mark the official partnership with the Genomic Medicine Alliance and the SEAPharm Consortium and will focus on the recent trends in the field of Pharmacogenomics ad Personalized Medicine. Lastly, the meeting will feature the 2015 Genomic Medicine Alliance - Public Health Genomics award, presented for the best abstract submitted for this meeting. As Chairman of the Organising Committee, I would like the opportunity of welcoming you to our capital city, Kuala Lumpur for a fruitful and stimulating exploration into “Next Generation Pharmacogenomics”.
The Golden Helix Symposia series are named after the house of Francis Crick (“The Golden Helix”; 19/20 Portugal Place, Cambridge, UK) to emphasize their focus on human genomics and personalized medicine. The topic of these symposia revolves around the fields of genomic and personalized medicine. In particular, these symposia series have the following features:
- Symposia topics are selected by Golden Helix Institute’s International Advisory Council of distinguished research scientists from academia, government, and industry.
- New and often ground- breaking science is presented at every meeting.
- Symposia range in length from 2 to 3 days
- Average attendance is 200 participants, with attendance ranging from 180 to 250 participants coming from various countries worldwide.
- Scientific excellence is ensured where important collaborations are formed, careers are enhanced, and new scientific breakthroughs are presented
- Participants are staff scientists, post-doctoral fellows and students from academia, working in the field of personalized research, and scientists from pharmaceutical and biotechnology industries, government agencies and private and research foundations,
- Conference venues are usually prestigious locations in major cities or summer retreats in Southern Mediterranean or Eastern regions